These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 26617224)

  • 1. Subcutaneous Immunotherapy and Sublingual Immunotherapy: Comparative Efficacy, Current and Potential Indications, and Warnings--United States Versus Europe.
    Nelson HS; Makatsori M; Calderon MA
    Immunol Allergy Clin North Am; 2016 Feb; 36(1):13-24. PubMed ID: 26617224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of sublingual immunotherapy in children.
    Arasi S; Passalacqua G; Caminiti L; Crisafulli G; Fiamingo C; Pajno GB
    Expert Rev Clin Immunol; 2016; 12(1):49-56. PubMed ID: 26496537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subcutaneous versus sublingual immunotherapy for allergic rhinitis and/or asthma.
    Bahceciler NN; Cobanoglu N
    Immunotherapy; 2011 Jun; 3(6):747-56. PubMed ID: 21668312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New applications for sublingual immunotherapy in allergy.
    Incorvaia C; Mauro M; Cappelletti T; Pravettoni C; Leo G; Riario-Sforza GG
    Recent Pat Inflamm Allergy Drug Discov; 2009 Jun; 3(2):113-7. PubMed ID: 19519587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selection of patients for sublingual versus subcutaneous immunotherapy.
    Larenas Linnemann DE; Blaiss MS
    Immunotherapy; 2014; 6(7):871-84. PubMed ID: 25290418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical efficacy of immunotherapy in allergic rhinitis.
    Oktemer T; Altıntoprak N; Muluk NB; Senturk M; Kar M; Bafaqeeh SA; Bellussi L; Passali D; Cingi C
    Am J Rhinol Allergy; 2016 Sep; 30(5):4-7. PubMed ID: 29025463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical efficacy of immunotherapy in allergic rhinitis.
    Oktemer T; Altıntoprak N; Muluk NB; Senturk M; Kar M; Bafaqeeh SA; Bellussi L; Passali D; Cingi C
    Am J Rhinol Allergy; 2016 Sep; 30(5):4-7. PubMed ID: 27658025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcutaneous immunotherapy versus sublingual immunotherapy: which is more effective?
    Nelson HS
    J Allergy Clin Immunol Pract; 2014; 2(2):144-9; quiz 150-1. PubMed ID: 24607040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sublingual or subcutaneous immunotherapy for allergic rhinitis?
    Durham SR; Penagos M
    J Allergy Clin Immunol; 2016 Feb; 137(2):339-349.e10. PubMed ID: 26853126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subcutaneous injection immunotherapy for optimal effectiveness.
    Nelson HS
    Immunol Allergy Clin North Am; 2011 May; 31(2):211-26, viii. PubMed ID: 21530815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies.
    Calderon MA; Casale TB; Nelson HS; Demoly P
    J Allergy Clin Immunol; 2013 Dec; 132(6):1322-36. PubMed ID: 24139829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultra short pre-seasonal subcutaneous immunotherapy and pre-coseasonal sublingual immunotherapy for pollen allergy: an evaluation of patient's preference in real life.
    Manzotti G; Pappacoda A; Dimatteo M; Scolari C; Riario-Sforza GG; Incorvaia C
    Eur Ann Allergy Clin Immunol; 2013 Aug; 45(4):138-43. PubMed ID: 24067339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of Aeroallergen Immunotherapy: Subcutaneous Immunotherapy and Sublingual Immunotherapy.
    Ozdemir C; Kucuksezer UC; Akdis M; Akdis CA
    Immunol Allergy Clin North Am; 2016 Feb; 36(1):71-86. PubMed ID: 26617228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical considerations in the use of sublingual immunotherapy for allergic rhinitis.
    Lee S; Nolte H; Benninger MS
    Am J Rhinol Allergy; 2015; 29(2):106-14. PubMed ID: 25785750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selection of patients for sublingual immunotherapy (SLIT) versus subcutaneous immunotherapy (SCIT).
    Tabatabaian F; Casale TB
    Allergy Asthma Proc; 2015; 36(2):100-4. PubMed ID: 25715238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perception and practice of sublingual immunotherapy among practicing allergists.
    Tucker MH; Tankersley MS;
    Ann Allergy Asthma Immunol; 2008 Oct; 101(4):419-25. PubMed ID: 18939732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient selection for subcutaneous versus sublingual immunotherapy.
    Larenas-Linnemann D
    Curr Opin Allergy Clin Immunol; 2015 Dec; 15(6):588-95. PubMed ID: 26485098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative efficacy and safety of subcutaneous versus sublingual immunotherapy.
    Bauer CS; Rank MA
    J Allergy Clin Immunol; 2014 Sep; 134(3):765-765.e2. PubMed ID: 25171871
    [No Abstract]   [Full Text] [Related]  

  • 19. Specific immunotherapy in children.
    Bufe A; Roberts G
    Clin Exp Allergy; 2011 Sep; 41(9):1256-62. PubMed ID: 21518041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allergen immunotherapy and asthma: efficacy, safety, and other considerations.
    Cox L
    Allergy Asthma Proc; 2008; 29(6):580-9. PubMed ID: 19173785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.